Live from the NIH registry
Studies recruiting near Peoria right now
Top 25 of 221 recruiting studies, sorted by proximity — each links to its official registry page
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Multiple conditions
N/A
Observational 2,900 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Illinois Cancer Care — Peoria, Illinois (4.3 mi)
· Sponsor: SCRI Development Innovations, LLC
Improving Safety, Patient Experience and Equity Through Shared Decision-making Huddles in Labor
Perinatal Decision Making
N/A
Interventional 2,200 participants sought
OSF St. Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Endeavor Health
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Peoria, Illinois (4.3 mi)
· Sponsor: Daiichi Sankyo
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Pancreatic Cancer, Pancreatic Cancer Metastatic
Phase 3
Interventional 570 participants sought
OSF Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Immuneering Corporation
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
OSF Saint Francis Medical Center — Peoria, Illinois (4.3 mi)
· Sponsor: Penumbra Inc.
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3
Interventional 562 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
Metastatic Castration-resistant Prostate Cancer (mCRPC), Prostatic Neoplasms
Phase 3
Interventional 1,314 participants sought
Illinois Cancer Care ( Site 0104) — Peoria, Illinois (4.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: SWOG Cancer Research Network
MASA Valve Early Feasibility Study
Tetrology of Fallot, Pulmonary Stenosis
N/A
Interventional 10 participants sought
OSF Childrens Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: PECA Labs
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Methodist Medical Center of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: Novo Nordisk A/S
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast Cancer, Locally Advanced Breast Cancer
Phase 3
Interventional 1,000 participants sought
Clinical Trial Site — Peoria, Illinois (4.3 mi)
· Sponsor: Olema Pharmaceuticals, Inc.
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
BBO-11818 in Adult Subjects With KRAS Mutant Cancer
Non-Small Cell Lung Cancer, NSCLC
Phase 1
Interventional 665 participants sought
OSF Healthcare Cancer Institute — Peoria, Illinois (4.3 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: NRG Oncology
A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)
Metastatic Colorectal Cancer
Phase 3
Interventional 1,020 participants sought
Illinois CancerCare PC — Peoria, Illinois (4.3 mi)
· Sponsor: EMD Serono Research & Development Institute, Inc.
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
OSF Children's Hospital of Illinois — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Illinois CancerCare-Peoria — Peoria, Illinois (4.3 mi)
· Sponsor: National Cancer Institute (NCI)